Supernus Pharmaceuticals Inc (SUPN)
35.81
-0.31
(-0.86%)
USD |
NASDAQ |
Nov 21, 16:00
35.81
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Market Cap: 1.977B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.995B |
| November 19, 2024 | 1.962B |
| November 18, 2024 | 1.946B |
| November 15, 2024 | 1.964B |
| November 14, 2024 | 1.998B |
| November 13, 2024 | 2.086B |
| November 12, 2024 | 2.089B |
| November 11, 2024 | 2.022B |
| November 08, 2024 | 2.021B |
| November 07, 2024 | 2.010B |
| November 06, 2024 | 2.085B |
| November 05, 2024 | 1.918B |
| November 04, 2024 | 1.916B |
| November 01, 2024 | 1.876B |
| October 31, 2024 | 1.881B |
| October 30, 2024 | 1.925B |
| October 29, 2024 | 1.898B |
| October 28, 2024 | 1.886B |
| October 25, 2024 | 1.874B |
| October 24, 2024 | 1.866B |
| October 23, 2024 | 1.870B |
| October 22, 2024 | 1.861B |
| October 21, 2024 | 1.859B |
| October 18, 2024 | 1.907B |
| October 17, 2024 | 1.869B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.876B |
| October 15, 2024 | 1.851B |
| October 14, 2024 | 1.818B |
| October 11, 2024 | 1.822B |
| October 10, 2024 | 1.761B |
| October 09, 2024 | 1.788B |
| October 08, 2024 | 1.795B |
| October 07, 2024 | 1.770B |
| October 04, 2024 | 1.768B |
| October 03, 2024 | 1.773B |
| October 02, 2024 | 1.776B |
| October 01, 2024 | 1.767B |
| September 30, 2024 | 1.722B |
| September 27, 2024 | 1.694B |
| September 26, 2024 | 1.696B |
| September 25, 2024 | 1.650B |
| September 24, 2024 | 1.685B |
| September 23, 2024 | 1.731B |
| September 20, 2024 | 1.753B |
| September 19, 2024 | 1.771B |
| September 18, 2024 | 1.755B |
| September 17, 2024 | 1.748B |
| September 16, 2024 | 1.735B |
| September 13, 2024 | 1.714B |
| September 12, 2024 | 1.703B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
759.12M
Minimum
Mar 18 2020
2.280B
Maximum
Feb 02 2023
1.558B
Average
1.580B
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 81.80B |
| United Therapeutics Corp | 16.38B |
| Ligand Pharmaceuticals Inc | 2.209B |
| Tonix Pharmaceuticals Holding Corp | 37.66M |
| Agios Pharmaceuticals Inc | 3.168B |
Market Cap Related Metrics
| PE Ratio | 33.48 |
| PS Ratio | 3.058 |
| PEG Ratio | 0.2081 |
| Price to Book Value | 1.963 |
| Price to Free Cash Flow | 11.59 |
| Price | 35.81 |
| Earnings Yield | 2.99% |
| PEGY Ratio | 0.2081 |
| Operating PE Ratio | 27.39 |
| Normalized PE Ratio | 28.31 |